Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964607730> ?p ?o ?g. }
- W2964607730 endingPage "29" @default.
- W2964607730 startingPage "13" @default.
- W2964607730 abstract "Immune checkpoint inhibitors (ICI) have emerged as a remarkable treatment option for diverse cancer types. Currently, ICIs are approved for an expanding array of cancer indications. However, the majority of patients still do not demonstrate a durable long-term response following ICI therapy. In addition, many patients receiving ICI therapy develop immune-related adverse events (irAEs) affecting a wide variety of organs. To increase the percentage of patients who benefit from ICI therapy and to reduce the occurrence of irAEs, there is an ongoing effort to combine current ICIs with novel checkpoints inhibitors or other therapeutic approaches to achieve a synergistic effect which is larger than the sum of its parts. In this review we highlight the essential factors for more effective ICI combinations. We describe how the design of these strategies should be driven by the tumor's immunological context. We analyze current combination strategies and describe how they can be improved to unleash the immune system's full anti-cancer potential as well as convert immunologically cold tumors into hot ones. We examine the efforts to combine current ICIs (PD-1 and CTLA-4) with novel checkpoints (TIM-3, LAG-3, VISTA, TIGIT and others), immunotherapies (CAR-T cells and Cancer Vaccines) and delivery strategies (bispecific antibodies and other delivery platforms). Importantly, we outline how can one optimally combine ICIs with traditional pillars of cancer therapy such as radiation therapy (RT) and chemotherapy. We discuss the considerations regarding successful combination with RT and chemotherapy; these include fractionation schemes and selection of chemotherapeutics which can both directly eradicate cancer cells as well as increase the infiltration of immune cells into tumors. Finally, we critically assess these approaches and attempt to establish their strengths and weaknesses based on pre-clinical and clinical data." @default.
- W2964607730 created "2019-08-13" @default.
- W2964607730 creator A5027096449 @default.
- W2964607730 creator A5050167650 @default.
- W2964607730 date "2019-07-01" @default.
- W2964607730 modified "2023-10-14" @default.
- W2964607730 title "Immune checkpoint inhibitor combinations: Current efforts and important aspects for success" @default.
- W2964607730 cites W1501839163 @default.
- W2964607730 cites W1556687169 @default.
- W2964607730 cites W1572739876 @default.
- W2964607730 cites W1853160207 @default.
- W2964607730 cites W1936170382 @default.
- W2964607730 cites W1974903851 @default.
- W2964607730 cites W1983076937 @default.
- W2964607730 cites W1987165863 @default.
- W2964607730 cites W1990515033 @default.
- W2964607730 cites W1991148746 @default.
- W2964607730 cites W2004911979 @default.
- W2964607730 cites W2026938154 @default.
- W2964607730 cites W2032166347 @default.
- W2964607730 cites W2035838265 @default.
- W2964607730 cites W2038681512 @default.
- W2964607730 cites W2068817764 @default.
- W2964607730 cites W2069200323 @default.
- W2964607730 cites W2079905136 @default.
- W2964607730 cites W2089103836 @default.
- W2964607730 cites W2093065396 @default.
- W2964607730 cites W2098156682 @default.
- W2964607730 cites W2098414192 @default.
- W2964607730 cites W2104343785 @default.
- W2964607730 cites W2117878645 @default.
- W2964607730 cites W2142604595 @default.
- W2964607730 cites W2142879592 @default.
- W2964607730 cites W2149121521 @default.
- W2964607730 cites W2158943617 @default.
- W2964607730 cites W2159022177 @default.
- W2964607730 cites W2166662937 @default.
- W2964607730 cites W2194989239 @default.
- W2964607730 cites W2208214508 @default.
- W2964607730 cites W2259730793 @default.
- W2964607730 cites W2268557403 @default.
- W2964607730 cites W2281666530 @default.
- W2964607730 cites W2347177886 @default.
- W2964607730 cites W2417522353 @default.
- W2964607730 cites W2463645998 @default.
- W2964607730 cites W2473489333 @default.
- W2964607730 cites W2474535137 @default.
- W2964607730 cites W2515527586 @default.
- W2964607730 cites W2529904548 @default.
- W2964607730 cites W2534058713 @default.
- W2964607730 cites W2536322725 @default.
- W2964607730 cites W2548694234 @default.
- W2964607730 cites W2552470435 @default.
- W2964607730 cites W2554094503 @default.
- W2964607730 cites W2559382297 @default.
- W2964607730 cites W2559827832 @default.
- W2964607730 cites W2570548560 @default.
- W2964607730 cites W2572843558 @default.
- W2964607730 cites W2581440655 @default.
- W2964607730 cites W2583925702 @default.
- W2964607730 cites W2587330058 @default.
- W2964607730 cites W2587691649 @default.
- W2964607730 cites W2588571054 @default.
- W2964607730 cites W2589987575 @default.
- W2964607730 cites W2591306501 @default.
- W2964607730 cites W2592785733 @default.
- W2964607730 cites W2594455756 @default.
- W2964607730 cites W2603526557 @default.
- W2964607730 cites W2607357764 @default.
- W2964607730 cites W2609813418 @default.
- W2964607730 cites W2621587943 @default.
- W2964607730 cites W2625222005 @default.
- W2964607730 cites W2625395613 @default.
- W2964607730 cites W2626752341 @default.
- W2964607730 cites W2676895855 @default.
- W2964607730 cites W2724264513 @default.
- W2964607730 cites W2747769029 @default.
- W2964607730 cites W2753778520 @default.
- W2964607730 cites W2754555242 @default.
- W2964607730 cites W2765943070 @default.
- W2964607730 cites W2769518734 @default.
- W2964607730 cites W2772084440 @default.
- W2964607730 cites W2772677509 @default.
- W2964607730 cites W2782708334 @default.
- W2964607730 cites W2783088287 @default.
- W2964607730 cites W2783914781 @default.
- W2964607730 cites W2791064759 @default.
- W2964607730 cites W2792398247 @default.
- W2964607730 cites W2792572471 @default.
- W2964607730 cites W2792937256 @default.
- W2964607730 cites W2793614926 @default.
- W2964607730 cites W2796643083 @default.
- W2964607730 cites W2801918257 @default.
- W2964607730 cites W2802206159 @default.
- W2964607730 cites W2804669050 @default.
- W2964607730 cites W2805945304 @default.
- W2964607730 cites W2886119834 @default.
- W2964607730 cites W2887901772 @default.